跳至主要内容
临床试验/NCT07677696
NCT07677696招募中不适用

A Prospective, Multicenter, Real-World Clinical Study Provides an Assessment of the Safety and Efficacy of Midline Catheters

Shandong Branden Med.Device Co.,Ltd1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2026年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10,000
试验地点
1
主要终点
Number of Participants With Catheter-Related Complications

研究概览

简要总结

The goal of this observational study is to learn about the safety and effectiveness of midline catheters in patients who receive midline catheter placement as part of their routine clinical care. The main question it aims to answer is:

Do midline catheters demonstrate acceptable safety and effectiveness when used in routine clinical practice?

Participants who receive a midline catheter as part of their regular medical care will have their clinical data collected from electronic medical records and patient questionnaires, and followed for outcomes related to catheter-related complications and functional performance.

详细描述

Study Title

A prospective multicenter real-world clinical study provides an assessment of the safety and efficacy of midline catheters

Study Description

Background and Why This Study Is Being Done

Midline catheters are intended for patients expected to require intravenous therapy for 1 to 4 weeks. They offer several advantages including rapid insertion, a high safety profile, low maintenance costs, and no need for X-ray confirmation of tip placement. Although midline catheters are widely used in clinical practice internationally, their adoption in China has been relatively late. Research on midline catheters in China remains limited and in its early stages without in-depth investigation.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • First-time midline catheter placement per physician order
  • Not enrolled in another clinical study
  • Willing and able to provide informed consent and comply with follow-up (unless consent waived by local ethics committee)

排除标准

  • Deemed unsuitable by investigator (e.g., poor compliance or inability to communicate clearly)
  • Refusal of informed consent by patient or family member

结局指标

主要结局

Number of Participants With Catheter-Related Complications

时间窗: From catheter insertion until removal, assessed up to 28 days

Catheter-related complications include phlebitis, catheter-related bloodstream infection (CRBSI), venous thrombosis, and catheter occlusion. Complication rate is calculated as the number of participants experiencing at least one complication divided by the total number of enrolled participants, multiplied by 100 percent.

次要结局

  • One-Time Insertion Success Rate(At catheter insertion, assessed up to 28 days)
  • Catheter Dwell Time(From catheter insertion to removal, assessed up to 28 days)
  • Unplanned Removal Rate(From catheter insertion to removal, assessed up to 28 days)
  • Insertion and Maintenance Cost(From catheter insertion to removal, assessed up to 28 days)
  • Patient Satisfaction(At catheter removal, , assessed up to 28 days)
  • Catheter Function Rate(At catheter removal, assessed up to 28 days)

研究者

发起方
Shandong Branden Med.Device Co.,Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验